Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(±)16,17-EDT, an oxylipin metabolite of adrenic acid produced through the cytochrome P450 (CYP) pathway, effectively induces dilation in isolated porcine arterioles (EC50 = 11 pM) and promotes relaxation of isolated bovine coronary arteries previously contracted by the TP receptor agonist U-46619.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 μg | 35 days | $ 123.00 | |
50 μg | 35 days | $ 220.00 | |
100 μg | 35 days | $ 418.00 | |
500 μg | 35 days | $ 1,830.00 |
Description | (±)16,17-EDT, an oxylipin metabolite of adrenic acid produced through the cytochrome P450 (CYP) pathway, effectively induces dilation in isolated porcine arterioles (EC50 = 11 pM) and promotes relaxation of isolated bovine coronary arteries previously contracted by the TP receptor agonist U-46619. |
Synonyms | (±)16,17-Epoxydocosatrienoic Acid, (±)-Dihomo-16,17-EET, (±)16,17-EpDoTrE |
Molecular Weight | 348.52 |
Formula | C22H36O3 |
CAS No. | 351533-79-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 10 mg/ml
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(±)16,17-EDT 351533-79-4 (±)16,17-Epoxydocosatrienoic Acid (±)-Dihomo-16,17-EET (±)16,17-EpDoTrE inhibitor inhibit